Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2012-04-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD002744.pub4PMID 22513907PMCID PMC6599832
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.

  2012cited by this paper
• Oseltamivir

  2012cited by this paper
• Clinical prediction rules combining signs, symptoms and epidemiological context to distinguish influenza from influenza-like illnesses in primary care: a cross sectional study

  2011cited by this paper
• Interventions for latent autoimmune diabetes (LADA) in adults.

  2011cited by this paper
• Systematic review of influenza resistance to the neuraminidase inhibitors

  2011cited by this paper
• Rapid diagnostic testing for seasonal influenza: an evidence-based review and comparison with unaided clinical diagnosis.

  2010cited by this paper
• Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial.

  2010cited by this paper
• Cochrane Handbook for Systematic Reviews of Interventions

  2010cited by this paper
• Impact of oseltamivir treatment on the incidence and course of acute otitis media in children with influenza.

  2010cited by this paper
• Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009

  2010cited by this paper
• Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate (CS-8958) versus Oseltamivir as Treatment for Children with Influenza Virus Infection

  2010cited by this paper
• Safety and pharmacokinetics of oseltamivir at standard and high dosages.

  2010cited by this paper
• Efficacy and Safety of Intravenous Peramivir for Treatment of Seasonal Influenza Virus Infection

  2010cited by this paper
• Clinical Pharmacokinetics of Laninamivir, a Novel Long‐Acting Neuraminidase Inhibitor, After Single and Multiple Inhaled Doses of Its Prodrug, CS‐8958, in Healthy Male Volunteers

  2010cited by this paper
• Relative Impact of Influenza and Respiratory Syncytial Virus in Young Children

  2009cited by this paper
• Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation.

  2009cited by this paper
• Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation.

  2009cited by this paper
• Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials

  2009cited by this paper
• Health Technology Assessment (HTA)

  2008cited by this paper
• A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B.

  2008cited by this paper
• The Global State of Influenza in Children

  2008cited by this paper
• CS-8958, a Prodrug of the New Neuraminidase Inhibitor R-125489, Shows Long-Acting Anti-Influenza Virus Activity

  2008cited by this paper
• Effectiveness of oseltamivir treatment among children with influenza A or B virus infections during four successive winters in Niigata City, Japan.

  2008cited by this paper
• Pharmacokinetics and Tolerability of Oseltamivir Combined with Probenecid

  2008cited by this paper
• Chapter 8: Assessing risk of bias in included studies

  2008cited by this paper
• Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review

  2008cited by this paper
• Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children.

  2008cited by this paper
• Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.

  2008cited by this paper
• Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children

  2008cited by this paper
• Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000-2005.

  2008cited by this paper
• Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir.

  2007cited by this paper
• Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.

  2007cited by this paper
• Antipyretic effect of Mao-to, a Japanese herbal medicine, for treatment of type A influenza infection in children.

  2007cited by this paper
• Neuraminidase inhibitors for preventing and treating influenza in children.

  2007cited by this paper
• Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children.

  2007cited by this paper
• Time to publication for results of clinical trials.

  2007cited by this paper
• Neuraminidase inhibitors for preventing and treating influenza in children.

  2007cited by this paper
• Duration of isolation of children with influenza A treated with oseltamivir

  2006cited by this paper
• A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons.

  2006cited by this paper
• The underrecognized burden of influenza in young children.

  2006cited by this paper
• Amantadine and rimantadine for influenza A in adults.

  2006cited by this paper
• A multicentre, randomized, controlled trial of oseltamivir in the treatment of influenza in a high-risk Chinese population*

  2006cited by this paper
• Experience with oseltamivir for infants younger than 1 year old in Japan.

  2005cited by this paper
• Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season.

  2005cited by this paper
• Oral Oseltamivir Improves Pulmonary Function and Reduces Exacerbation Frequency for Influenza-Infected Children With Asthma

  2005cited by this paper
• Oseltamivir phosphate in infants under 1 year of age with influenza infection

  2005cited by this paper
• Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma.

  2005cited by this paper
• HOSPITAL-BASED EPIDEMIOLOGIC SURVEY OF MALIGNANCIES IN CHILDREN INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS IN THAILAND

  2005cited by this paper
• Neuraminidase inhibitors for influenza.

  2005cited by this paper
• Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis.

  2004cited by this paper
• Oseltamivir prophylaxis during the influenza season in a paediatric cancer centre: prospective observational study.

  2004cited by this paper
• [Effect of post-exposure prophylaxis with oseltamivir for those in contacts with influenza patients in pediatric wards].

  2004cited by this paper
• Guidelines on neuraminidase inhibitors in children are not supported by evidence

  2004cited by this paper
• Resistant influenza A viruses in children treated with oseltamivir: descriptive study.

  2004cited by this paper
• Oseltamivir-resistant influenza?

  2004cited by this paper
• [A multicenter randomized controlled study of the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population].

  2004cited by this paper
• Skin Reactions in Patients with Influenza Treated with Oseltamivir: A Retrospective Cohort Study

  2004cited by this paper
• [Cost effectiveness analysis of oseltamivir phosphorus in the treatment of influenza].

  2004cited by this paper
• [A multicenter study of efficacy and safety of oseltamivir in the treatment of suspected influenza patients].

  2004cited by this paper
• [Appropriate use of rapid diagnostic testing for influenza].

  2004cited by this paper
• Use of Oseltamivir to control influenza complications after bone marrow transplantation

  2004cited by this paper
• Effect of Influenza Treatment with Oseltamivir on Health Outcome and Costs in Otherwise Healthy Children

  2004cited by this paper
• [Investigation of the reconsultation rate and pharmacoeconomic evaluation of period of influenza treatment by oseltamivir].

  2003cited by this paper
• [The study on efficacy of oseltamivir for influenza A in children].

  2003cited by this paper
• Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1–5 years

  2003cited by this paper
• Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials

  2003cited by this paper
• Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.

  2003cited by this paper
• [Effectiveness of oseltamivir on influenza and influencing factors: age of patients, type of influenza virus and timing of initial administration].

  2003cited by this paper
• Neuraminidase inhibitors for preventing and treating influenza in children.

  2003cited by this paper
• Safety and Pharmacology of Oseltamivir in Clinical Use

  2003cited by this paper
• [Effectiveness of oseltamivir treatment against influenza type A and type B infection in children].

  2002cited by this paper
• Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study.

  2002cited by this paper
• Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.

  2002cited by this paper
• Evaluation of diagnostic tests for influenza in a pediatric practice

  2002cited by this paper
• The effect of zanamivir treatment on influenza complications: a retrospective cohort study.

  2002cited by this paper
• Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households.

  2002cited by this paper
• Neuraminidase inhibitors in the management of influenza – experience of an outpatient practice

  2002cited by this paper
• Influenza virus neuraminidase inhibitors: clinical aspects

  2001cited by this paper
• Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials.

  2001cited by this paper
• Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study.

  2001cited by this paper
• Oral oseltamivir treatment of influenza in children

  2001cited by this paper
• Position statement: global neuraminidase inhibitor susceptibility network.

  2001cited by this paper
• Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial.

  2001cited by this paper
• Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial

  2000cited by this paper
• [Clinical efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir in treating acute influenza--placebo-controlled double-blind multicenter phase III trial].

  2000cited by this paper
• Influenza and the rates of hospitalization for respiratory disease among infants and young children.

  2000cited by this paper
• Presentation with influenza-like illness in general practice: implications for use of neuraminidase inhibitors.

  2000cited by this paper
• Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.

  2000cited by this paper
• Pharmacokinetics and Tolerability of a Single Inhaled Dose of Zanamivir in Children

  2000cited by this paper
• Efficacy and Safety of Inhaled Zanamivir for the Treatment of Influenza in Patients with Asthma or Chronic Obstructive Pulmonary Disease

  2000cited by this paper
• Respiratory distress associated with zanamivir.

  2000cited by this paper
• Population-Based Study on Incidence, Risk Factors, Clinical Complications and Drug Utilisation Associated with Influenza in the United Kingdom

  2000cited by this paper
• An evidence based approach to reducing antibiotic use in children with acute otitis media: controlled before and after study

  1999cited by this paper
• The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.

  1998cited by this paper
• Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus.

  1998cited by this paper
• The Published Data

  1990cited by this paper
• Estimating household and community transmission parameters for influenza.

  1982cited by this paper
• Interpandemic influenza in the Houston area, 1974-76.

  1978cited by this paper
• Resistant influenza A viruses in children treated with oseltamivir : descriptive study

  year unknowncited by this paper

• Hepatitis is an underestimated complication among children with pneumonia associated with SARS-CoV-2 and influenza: a single center study

  2026cites this paper
• Clinician Preferences for Oseltamivir Use in Children With Influenza in the Outpatient Setting.

  2025cites this paper
• Characteristics of children with influenza admitted to a pediatric hospital in Greece during the 2022/2023 and 2023/2024 seasons

  2025cites this paper
• Variability of Clinician Recommendations for Oseltamivir in Children Hospitalized With Influenza.

  2025cites this paper
• Recommendations for Prevention and Control of Influenza in Children, 2025-2026: Technical Report.

  2025cites this paper
• Respiratory infections in low and middle-income countries.

  2024cites this paper
• A noninferiority randomized open-label pilot study of 3- versus 7-day influenza postexposure prophylaxis with oseltamivir in hospitalized children

  2024cites this paper
• Recommendations for Prevention and Control of Influenza in Children, 2024-2025: Technical Report.

  2024cites this paper
• A Systematic Review of Clinical Pharmacokinetics of Inhaled Antiviral

  2023cites this paper
• Recommendations for Prevention and Control of Influenza in Children, 2023-2024.

  2023cites this paper
• Influenza presentations and use of neuraminidase inhibitors by Australian general practice registrars: a cross-sectional analysis from the ReCEnT study

  2023cites this paper
• An overview of the characteristics and methodological standards across systematic reviews with Meta-analysis of efficacy/effectiveness of influenza antiviral drugs

  2022cites this paper
• Recommendations for Prevention and Control of Influenza in Children, 2022-2023.

  2022cites this paper
• Evaluation of the Clinical Effectiveness of Oseltamivir for Influenza Treatment in Children

  2022cites this paper
• Pathophysiological effects of Tamiflu on liver and kidneys of male rats

  2022cites this paper
• Characteristics of viral pneumonia in the COVID-19 era: an update

  2021cites this paper
• Neuraminidase inhibitors and single dose baloxavir are effective and safe in uncomplicated influenza: a meta-analysis of randomized controlled trials

  2021cites this paper
• Clinical efficacy of respiratory virus detection by using the FilmArray method in children admitted with respiratory infection

  2021cites this paper
• Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC4E Trial

  2021cites this paper
• Recommendations for Prevention and Control of Influenza in Children, 2021–2022

  2021cites this paper
• The use of antiviral drugs in children

  2021cites this paper
• Recommendations for Prevention and Control of Influenza in Children, 2020–2021

  2020cites this paper
• Antiviraux chez l’enfant en pratique de ville : infections herpétiques, varicelle, grippe

  2020cites this paper
• Respiratory Virus Infection: Recent Advances

  2020cites this paper
• [A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients].

  2020cites this paper
• Recommendations for Prevention and Control of Influenza in Children, 2019–2020

  2019cites this paper
• Drugs for Influenza Treatment: Is There Significant News?

  2019cites this paper
• Room Sharing in Hospitalized Children With Bronchiolitis and the Occurrence of Hospital-Acquired Infections: A Prospective Cohort Study.

  2019cites this paper
• A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients

  2019cites this paper
• Rescue of four pediatric patients with severe influenza A (H3N2) in Weifang, China

  2018cites this paper
• The effect of neuraminidase inhibitors on household transmission in Japanese patients with influenza A and B infection: A prospective, observational study

  2018cites this paper
• Recommendations for Prevention and Control of Influenza in Children, 2018–2019

  2018cites this paper
• Pharmacy‐based management of influenza: lessons learned from research

  2018cites this paper
• Testing for Respiratory Viruses in Children: To Swab or Not to Swab

  2017cites this paper
• The Effectiveness of Trivalent Inactivated Influenza Vaccine in Children with Acute Leukemia

  2017cites this paper
• Safety and effectiveness of neuraminidase inhibitors for influenza treatment, prophylaxis, and outbreak control: a systematic review of systematic reviews and/or meta-analyses

  2017cites this paper
• Protecting young children from influenza

  2017cites this paper
• Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years

  2017cites this paper
• Arbidol for preventing and treating influenza in adults and children

  2017cites this paper
• Oseltamivir for influenza infection in children: risks and benefits

  2016cites this paper
• Expert Opinion on neuraminidase inhibitors for prevention and treatment of influenza – review of recent systematic reviews and meta-analyses

  2016influential citation
• Impact of oseltamivir use on the reduction of complications in patients with influenza: a prospective study

  2016cites this paper
• Antivirale Arzneimittel bei saisonaler und pandemischer Influenza

  2016cites this paper
• Antiviral Medications in Seasonal and Pandemic Influenza.

  2016cites this paper
• Influenza in the Emergency Department: Vaccination, Diagnosis, and Treatment: Clinical Practice Paper Approved by American Academy of Emergency Medicine Clinical Guidelines Committee.

  2016cites this paper
• Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context

  2016cites this paper
• [Seasonality in asthma: Impact and treatments].

  2016cites this paper
• Uncomplicated pneumonia in healthy Canadian children and youth: Practice points for management.

  2015cites this paper
• Virus-induced secondary bacterial infection: a concise review

  2015cites this paper
• Uncomplicated pneumonia in healthy Canadian children and youth: Practice points for management.

  2015cites this paper
• The Role of Viral Infection in Pulmonary Exacerbations of Bronchiectasis in Adults

  2015cites this paper
• Homeopathic Oscillococcinum® for preventing and treating influenza and influenza-like illness.

  2015cites this paper
• La pneumonie non compliquée chez les enfants et les adolescents canadiens en santé : points de pratique sur la prise en charge

  2015cites this paper
• In-silico structural analysis of the influenza A subtype H7N9 neuraminidase and molecular docking with different neuraminidase inhibitors

  2015cites this paper
• A prospective observational study of oseltamivir safety and tolerability in infants and young children ≤24 months

  2015cites this paper
• Review of Non-bacterial Infections in Respiratory Medicine: Viral Pneumonia

  2015cites this paper
• Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments

  2014cites this paper
• Treatment with neuraminidase inhibitors for high-risk patients with influenza: why is adherence to antiviral treatment recommendations so low?

  2014cites this paper
• Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports

  2014cites this paper
• Financial Conflicts of Interest and Conclusions About Neuraminidase Inhibitors for Influenza

  2014cites this paper
• Revenue effects of practice nurse-led care for chronic diseases.

  2014cites this paper
• Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments

  2014cites this paper
• Respiratory viruses in exacerbations of non-cystic fibrosis bronchiectasis in children

  2014cites this paper
• Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load.

  2014cites this paper
• Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial

  2014cites this paper
• The Common Cold: Potential for Future Prevention or Cure

  2014cites this paper
• Mucosal Immune Responses Predict Clinical Outcomes during In fl uenza Infection Independently of Age and Viral Load Christine

  2014cites this paper
• Clinical and Laboratory Findings of the 2012 Winter Seasonal Influenza A and B Outbreak at a Single Institution

  2014cites this paper
• USE OF COMPUTATIONAL MATRIX ADJUSTMENT TO EVALUATE THE EFFECTIVENESS OF COMMON INFLUENZA VACCINES AGAINST THE EMERGENCE OF DRIFT VARIANTS

  2014cites this paper
• Risk factors for need of mechanical ventilation in children with influenza A(H1N1)pdm09.

  2013cites this paper
• H1N1 pandemic: clinical and epidemiologic characteristics of the Canadian pediatric outbreak

  2013cites this paper
• Protecting Pediatric Oncology Patients From Influenza

  2013cites this paper
• Differential use of antivirals for treatment of patients with influenza A(H1N1)pdm09 in Germany

  2013cites this paper
• The Value of Neuraminidase Inhibitors for the Prevention and Treatment of Seasonal Influenza: A Systematic Review of Systematic Reviews

  2013influential citation
• The burden of seasonal and pandemic influenza in infants and children

  2013cites this paper
• Chinese medicinal herbs for influenza.

  2013cites this paper
• Clinical features of influenza disease in admitted children during the first postpandemic season and risk factors for hospitalization: a multicentre Spanish experience.

  2013cites this paper
• The Novel Antiviral Pipeline to Treat Severe Neonatal Viral Infections

  2013cites this paper
• Studying use and risks of medicines in children: a European approach

  2013cites this paper
• Kapitel 46 – Influenza

  2013cites this paper
• Protecting pediatric oncology patients from influenza.

  2013cites this paper
• Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.

  2013cites this paper
• Protecting Pediatric Oncology Patients From Influenza

  2013cites this paper
• Double dose oseltamivir for severe influenza—does it help?

  2013cites this paper
• Homeopathic Oscillococcinum(®) for preventing and treating influenza and influenza-like illness.

  2012cites this paper
• Fatores associados à gravidade da infecção por influenza A pandêmico (H1N1) 2009 em pacientes pediátricos hospitalizados

  2012cites this paper
• Antivirals for Treatment of Influenza

  2012cites this paper
• Are neuraminidase inhibitors effective for preventing and treating influenza in healthy adults and children?

  2012cites this paper
• Investigating the aetiology of respiratory tract infections in children admitted to Tygerberg Children’s Hospital using molecular methods and viral culture

  2012cites this paper
• Influenza vaccines and vaccinations in Poland – past, present and future

  2012cites this paper
• Prevention of influenza in healthy children

  2012cites this paper
• Risk Factors for Need of Mechanical Ventilation in Children with Influenza A(h1n1)pdm09 Este É Um Artigo Open Access Sob a Licença De Cc By-nc-nd Palavras-chave

  year unknowncites this paper